Thalassemia differential diagnosis: Difference between revisions
Jump to navigation
Jump to search
Shyam Patel (talk | contribs) No edit summary |
Ahmed Younes (talk | contribs) No edit summary |
||
(10 intermediate revisions by 2 users not shown) | |||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{ | [[Image:Home_logo1.png|right|250px|link=https://www.wikidoc.org/index.php/Thalassemia]] | ||
{{ | {{CMG}}; {{AE}}{{shyam}} | ||
==Overview== | ==Overview== | ||
A variety of diseases can mimic thalassemia. These include sickle cell anemia, iron-deficiency anemia, hemolytic anemia, sideroblastic anemia, anemia of chronic disease, vitamin B12 deficiency, and erythropoietin deficiency. It is important to distinguish amongst these conditions, as each condition has different clinical consequences and treatment considerations. | |||
==Differential Diagnosis== | ==Differential Diagnosis== | ||
Line 24: | Line 24: | ||
* [[Microcytic]] (<80 femtoliter) in most cases | * [[Microcytic]] (<80 femtoliter) in most cases | ||
| | | | ||
* Abnormal [[hemoglobin]] [[electrophoresis]] | * Abnormal [[hemoglobin]] [[electrophoresis]] | ||
* | * Abnormal [[high performance liquid chromatography]]<ref name="pmid16461765">{{cite journal| author=Chui DH, Cunningham MJ, Luo HY, Wolfe LC, Neufeld EJ, Steinberg MH| title=Screening and counseling for thalassemia. | journal=Blood | year= 2006 | volume= 107 | issue= 4 | pages= 1735-7 | pmid=16461765 | doi=10.1182/blood-2005-09-3557 | pmc=1895412 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16461765 }} </ref> | ||
* Elevated ferritin (due to frequent transfusions and iron overload) | * Elevated ferritin (due to frequent transfusions and iron overload) | ||
* Microcytic hypochromic anemia | |||
| | | | ||
* [[Irritability]] | * [[Irritability]] | ||
Line 40: | Line 41: | ||
| | | | ||
* [[Extramedullary hematopoiesis]] | * [[Extramedullary hematopoiesis]] | ||
* [[Mental retardation]]<ref name="pmid23028133">{{cite journal| author=Gibbons RJ| title=α-Thalassemia, mental retardation, and myelodysplastic syndrome. | journal=Cold Spring Harb Perspect Med | year= 2012 | volume= 2 | issue= 10 | pages= | pmid=23028133 | doi=10.1101/cshperspect.a011759 | pmc=3475406 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23028133 }} </ref> | |||
* [[Myelodysplastic syndrome]]<ref name="pmid23028133">{{cite journal| author=Gibbons RJ| title=α-Thalassemia, mental retardation, and myelodysplastic syndrome. | journal=Cold Spring Harb Perspect Med | year= 2012 | volume= 2 | issue= 10 | pages= | pmid=23028133 | doi=10.1101/cshperspect.a011759 | pmc=3475406 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23028133 }} </ref> | |||
|- | |||
||[[Sickle cell anemia]] | |||
| | |||
* [[Genetic defect]] resulting in sickled hemoglobin | |||
* Point mutation in beta-globin chain, converting glutamic acid to valine | |||
| | |||
* [[Microcytic]] (<80 femtoliter) or normocytic | |||
| | |||
* Abnormal [[hemoglobin]] [[electrophoresis]] with elevated HbSS fraction | |||
* Sickled [red blood cells]] on peripheral blood smear | |||
* Elevated ferritin (due to frequent transfusions and iron overload) | |||
* Elevated [[red blood cell]] mass | |||
| | |||
* Vaso-occlusion in peripheral vascular beds | |||
* [[Jaundice]] from hemolysis | |||
* [[Hepatomegaly]] | |||
* [[Splenomegaly]] | |||
| | |||
* Folate supplemention | |||
* Hydroxyurea (to increase fetal [[hemoglobin]] production | |||
* Oxygen supplemention | |||
* [[Blood transfusion|Transfusion]] support | |||
* [[Iron]] chelation | |||
* [[Gene therapy]] if available | |||
* Crizanlizumab (P-selectin inhibitor) | |||
* Patient education and genetic counseling | |||
| | |||
* [[Extramedullary hematopoiesis]] | |||
* Pain crises | |||
* Acute chest syndrome | |||
|- | |- | ||
|[[Iron deficiency anemia]] | |[[Iron deficiency anemia]] | ||
Line 65: | Line 98: | ||
|- | |- | ||
|[[Hemolytic anemia]] | |[[Hemolytic anemia]] | ||
| | |||
* Medication-induced | |||
* [[Autoimmunity]] | |||
* [[Red blood cell]] membrane defect | |||
* [[Red blood cell]] enzyme defect | |||
* Shear stress from mechanical valves | |||
| | | | ||
* [[Normocytic anemia|Normocytic]] (80-100 femtoliter) | * [[Normocytic anemia|Normocytic]] (80-100 femtoliter) | ||
Line 137: | Line 176: | ||
| | | | ||
* [[Inflammatory bowel disease]] | * [[Inflammatory bowel disease]] | ||
|- | |- | ||
|[[Erythropoietin]] deficiency | |[[Erythropoietin]] deficiency | ||
Line 219: | Line 217: | ||
* [[Neuropathy]] | * [[Neuropathy]] | ||
|} | |} | ||
==References== | ==References== |
Latest revision as of 20:30, 27 February 2019
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Shyam Patel [2]
Overview
A variety of diseases can mimic thalassemia. These include sickle cell anemia, iron-deficiency anemia, hemolytic anemia, sideroblastic anemia, anemia of chronic disease, vitamin B12 deficiency, and erythropoietin deficiency. It is important to distinguish amongst these conditions, as each condition has different clinical consequences and treatment considerations.
Differential Diagnosis
Characteristic/Parameter | Etiology | Mean corpuscular volume | Laboratory abnormalities | Physical examination | Treatment | Other associated abnormalities |
---|---|---|---|---|---|---|
Thalassemia |
|
|
|
|
||
Sickle cell anemia |
|
|
|
|
|
|
Iron deficiency anemia |
|
|
|
|
|
|
Hemolytic anemia |
|
|
|
|
||
Sideroblastic anemia |
Or
|
|
|
|||
Anemia of chronic disease |
|
|
|
|||
Erythropoietin deficiency |
|
|
|
|
| |
Vitamin B12 or folate deficiency |
|
|
|
References
- ↑ Chui DH, Cunningham MJ, Luo HY, Wolfe LC, Neufeld EJ, Steinberg MH (2006). "Screening and counseling for thalassemia". Blood. 107 (4): 1735–7. doi:10.1182/blood-2005-09-3557. PMC 1895412. PMID 16461765.
- ↑ 2.0 2.1 Gibbons RJ (2012). "α-Thalassemia, mental retardation, and myelodysplastic syndrome". Cold Spring Harb Perspect Med. 2 (10). doi:10.1101/cshperspect.a011759. PMC 3475406. PMID 23028133.
- ↑ Platzbecker U, Symeonidis A, Oliva EN, Goede JS, Delforge M, Mayer J; et al. (2017). "A phase 3 randomized placebo-controlled trial of darbepoetin alfa in patients with anemia and lower-risk myelodysplastic syndromes". Leukemia. 31 (9): 1944–1950. doi:10.1038/leu.2017.192. PMC 5596208. PMID 28626220.